Abawi, A.; Thomann, C.; Lollo, G.; Granjon, T.; Petiot, E.; Bérot, A.; Oger, C.; Bultel-Poncé, V.; Guy, A.; Galano, J.-M.;
et al. Carrier–Tumor Cell Membrane Interactions for Optimized Delivery of a Promising Drug, 4(RS)-4-F4t-Neuroprostane. Pharmaceutics 2023, 15, 2739.
https://doi.org/10.3390/pharmaceutics15122739
AMA Style
Abawi A, Thomann C, Lollo G, Granjon T, Petiot E, Bérot A, Oger C, Bultel-Poncé V, Guy A, Galano J-M,
et al. Carrier–Tumor Cell Membrane Interactions for Optimized Delivery of a Promising Drug, 4(RS)-4-F4t-Neuroprostane. Pharmaceutics. 2023; 15(12):2739.
https://doi.org/10.3390/pharmaceutics15122739
Chicago/Turabian Style
Abawi, Ariana, Céline Thomann, Giovanna Lollo, Thierry Granjon, Emma Petiot, Anna Bérot, Camille Oger, Valérie Bultel-Poncé, Alexandre Guy, Jean-Marie Galano,
and et al. 2023. "Carrier–Tumor Cell Membrane Interactions for Optimized Delivery of a Promising Drug, 4(RS)-4-F4t-Neuroprostane" Pharmaceutics 15, no. 12: 2739.
https://doi.org/10.3390/pharmaceutics15122739
APA Style
Abawi, A., Thomann, C., Lollo, G., Granjon, T., Petiot, E., Bérot, A., Oger, C., Bultel-Poncé, V., Guy, A., Galano, J.-M., Durand, T., Girard-Egrot, A., & Maniti, O.
(2023). Carrier–Tumor Cell Membrane Interactions for Optimized Delivery of a Promising Drug, 4(RS)-4-F4t-Neuroprostane. Pharmaceutics, 15(12), 2739.
https://doi.org/10.3390/pharmaceutics15122739
